JPS63115822A - 生理活性ポリペプチド類の経鼻投与用粉末状組成物 - Google Patents
生理活性ポリペプチド類の経鼻投与用粉末状組成物Info
- Publication number
- JPS63115822A JPS63115822A JP61260636A JP26063686A JPS63115822A JP S63115822 A JPS63115822 A JP S63115822A JP 61260636 A JP61260636 A JP 61260636A JP 26063686 A JP26063686 A JP 26063686A JP S63115822 A JPS63115822 A JP S63115822A
- Authority
- JP
- Japan
- Prior art keywords
- water
- composition according
- absorbing
- composition
- soluble
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61260636A JPS63115822A (ja) | 1986-11-04 | 1986-11-04 | 生理活性ポリペプチド類の経鼻投与用粉末状組成物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61260636A JPS63115822A (ja) | 1986-11-04 | 1986-11-04 | 生理活性ポリペプチド類の経鼻投与用粉末状組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63115822A true JPS63115822A (ja) | 1988-05-20 |
| JPH0480008B2 JPH0480008B2 (esLanguage) | 1992-12-17 |
Family
ID=17350671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61260636A Granted JPS63115822A (ja) | 1986-11-04 | 1986-11-04 | 生理活性ポリペプチド類の経鼻投与用粉末状組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS63115822A (esLanguage) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990005535A1 (fr) * | 1988-11-14 | 1990-05-31 | Otsuka Pharmaceutical Co., Ltd. | Preparation a base d'interferon pour administration nasale |
| GB2218098B (en) * | 1988-04-30 | 1991-11-20 | Sandoz Ltd | Acid addition salts of amidated taurine or glycine,their preparation and use |
| GB2303064A (en) * | 1995-07-12 | 1997-02-12 | Ltt Inst Co Ltd | Ion-exchange resin particles for nasal administration of vaccines and peptides |
| WO1998047490A1 (de) * | 1997-04-18 | 1998-10-29 | Roche Diagnostics Gmbh | Stabile pharmazeutische darreichungsform für peptide, proteine und nukleinsäuren |
| US6552074B2 (en) * | 2000-11-16 | 2003-04-22 | Fukumi Morishige | Arginine/ascorbic acid mixed powder as an oral supplement |
| WO2004078211A1 (ja) * | 2003-03-04 | 2004-09-16 | Tanabe Seiyaku Co., Ltd. | 粉末経鼻投与製剤 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56140924A (en) * | 1980-04-04 | 1981-11-04 | Teijin Ltd | Calcitonin pharmaceutical preparation |
| JPS60224616A (ja) * | 1984-04-24 | 1985-11-09 | Teijin Ltd | 経鼻投与用組成物 |
| JPS61118325A (ja) * | 1984-11-12 | 1986-06-05 | Yamanouchi Pharmaceut Co Ltd | 塩基性および/または中性アミノ酸を含有するカルシトニン経鼻剤 |
-
1986
- 1986-11-04 JP JP61260636A patent/JPS63115822A/ja active Granted
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56140924A (en) * | 1980-04-04 | 1981-11-04 | Teijin Ltd | Calcitonin pharmaceutical preparation |
| JPS60224616A (ja) * | 1984-04-24 | 1985-11-09 | Teijin Ltd | 経鼻投与用組成物 |
| JPS61118325A (ja) * | 1984-11-12 | 1986-06-05 | Yamanouchi Pharmaceut Co Ltd | 塩基性および/または中性アミノ酸を含有するカルシトニン経鼻剤 |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2218098B (en) * | 1988-04-30 | 1991-11-20 | Sandoz Ltd | Acid addition salts of amidated taurine or glycine,their preparation and use |
| WO1990005535A1 (fr) * | 1988-11-14 | 1990-05-31 | Otsuka Pharmaceutical Co., Ltd. | Preparation a base d'interferon pour administration nasale |
| GB2303064A (en) * | 1995-07-12 | 1997-02-12 | Ltt Inst Co Ltd | Ion-exchange resin particles for nasal administration of vaccines and peptides |
| GB2303064B (en) * | 1995-07-12 | 1999-10-06 | Ltt Inst Co Ltd | Medicament for nasal administration |
| WO1998047490A1 (de) * | 1997-04-18 | 1998-10-29 | Roche Diagnostics Gmbh | Stabile pharmazeutische darreichungsform für peptide, proteine und nukleinsäuren |
| AU744777B2 (en) * | 1997-04-18 | 2002-03-07 | Roche Diagnostics Gmbh | Stable pharmaceutical administration forms of peptides, proteins and nucleic acids |
| US6552074B2 (en) * | 2000-11-16 | 2003-04-22 | Fukumi Morishige | Arginine/ascorbic acid mixed powder as an oral supplement |
| US7214709B2 (en) | 2000-11-16 | 2007-05-08 | Eiji Kimoto | Arginine/ascorbic acid mixed powder as an oral supplement |
| WO2004078211A1 (ja) * | 2003-03-04 | 2004-09-16 | Tanabe Seiyaku Co., Ltd. | 粉末経鼻投与製剤 |
| US7591999B2 (en) | 2003-03-04 | 2009-09-22 | Mitsubishi Tanabe Pharma Corporation | Powdery preparation for nasal administration |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0480008B2 (esLanguage) | 1992-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3249147B2 (ja) | 生理活性蛋白含有経口製剤 | |
| EP0122036B2 (en) | Powdery pharmaceutical composition for nasal administration | |
| JP2851627B2 (ja) | 粉末形態ポリプペチド類の経鼻投与 | |
| JPS632932A (ja) | 経鼻投与用粉末状組成物 | |
| US4985242A (en) | Intranasally applicable powdery pharmaceutical composition | |
| JP3422775B2 (ja) | 高分子医薬品含有粉末状経粘膜投与製剤 | |
| CN1160127C (zh) | 粉状经鼻组合物 | |
| JPWO2000002574A1 (ja) | 高分子医薬品含有粉末状経粘膜投与製剤 | |
| CA2403962C (en) | Powdery preparation for transmucosal administration comprising a medicine of high molecular weight and exhibiting an improved storage stability | |
| JPH09208485A (ja) | ペプチド・蛋白質性薬物の水難溶性組成物 | |
| JPH05508616A (ja) | 治療用エアロゾル剤 | |
| JP2002187852A (ja) | 生理活性ペプチド含有粉末 | |
| JPS6242888B2 (esLanguage) | ||
| JP2505430B2 (ja) | 塩基性アミノ酸を含有する経鼻投与用粉末状組成物 | |
| JP3197221B2 (ja) | 吸収性が改善された粉末状経鼻投与組成物 | |
| JP2000504696A (ja) | 安定化された成長ホルモン処方物およびその製造方法 | |
| Niu et al. | FDA perspective on peptide formulation and stability issues | |
| JPH08277226A (ja) | 経鼻吸収用生理活性ペプチド組成物 | |
| CA2291765A1 (en) | Pharmaceutical compositions of peptides having low solubility in physiological medium | |
| JPS63115822A (ja) | 生理活性ポリペプチド類の経鼻投与用粉末状組成物 | |
| JPH09291026A (ja) | 即効性と持続性を兼ね備えた粉末状経鼻投与用組成物 | |
| JPH0338255B2 (esLanguage) | ||
| WO1999039730A1 (en) | Oral preparations containing peptides promoting the secretion of growth hormone | |
| JPS63115820A (ja) | アスコルビン酸類を含有する経鼻投与用粉末状組成物 | |
| JP3197222B2 (ja) | 粉末状経鼻投与組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |